Fairman Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-4
Closed -$576 – 324
2024
Q4
$576 Sell
4
-4
-50% -$574 ﹤0.01% 307
2024
Q3
$1.19K Hold
8
– – ﹤0.01% 324
2024
Q2
$1.01K Hold
8
– – ﹤0.01% 331
2024
Q1
$1.47K Hold
8
– – ﹤0.01% 297
2023
Q4
$1.44K Buy
+8
New +$1.25K ﹤0.01% 294

Other funds holding RGEN

Fairman Group's RGEN Position: Q1 2025 in Review

Fairman Group sold out of Repligen (RGEN) in Q1 2025, closing a stake of 4 shares — an estimated $576 sold.

Fairman Group first reported a position in RGEN in Q4 2023 and held it in 5 quarters. The position peaked at $1.47K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Fairman Group reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Fairman Group sold 4 Repligen shares in Q1 2025, an estimated $576.
  • Fairman Group first reported a position in Repligen in Q4 2023 and held it in 5 quarters.
  • Fairman Group's Repligen position peaked at $1.47K in Q1 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.